Acetaminophen vs Placebo in the Pre-operative Setting and Outcomes on Post-operative Pain, Nausea and Vomiting (IV)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02102555|
Recruitment Status : Terminated (study closed due to difficulty enrolling subjects - no results)
First Posted : April 3, 2014
Last Update Posted : January 14, 2020
|Condition or disease||Intervention/treatment||Phase|
|Post Operative Pain Post Operative Nausea and Vomiting||Drug: IV acetaminophen Drug: placebo||Phase 3|
The purpose of this study is to determine if using a one time pre-operative dose of IV acetaminophen has an effect on post-operative nausea, vomiting, and pain. This is a randomized, double-blind, placebo-controlled prospective study on patients from the Katzmann Breast Center undergoing outpatient breast surgery (including excisional biopsy, lumpectomy, sentinel lymph node biopsy, axillary node dissection, or ductal excision).
IV acetaminophen (paracetamol) has been in Europe and other countries. In the U.S. the FDA approved IV acetaminophen (Ofirmev) in November of 2010. Since then, it has been used in many different ways, but most commonly in the first 24 hours post operative recovery period.
There will be two arms included in this study. Patients in Arm One will receive a one gram dose of IV acetaminophen in the pre-operative area. Patients in Arm Two will receive a dose of the placebo (IV normal saline). The medication will be disguised in the same bag as the normal saline, so no one (including the patient) in the pre-operative area will know which arm the patient is in. This prospective, randomized, double blind study will compare post-operative nausea, vomiting, and pain rates in patients from both arms.
The primary endpoint of this study will be to compare post-operative pain in patients receiving a pre-operative dose of IV acetaminophen to patients receiving the normal saline placebo. Secondary endpoints will include post-operative nausea and vomiting, recovery times, and overall satisfaction of pain management throughout their experience (assessed on post operative day one). If this study shows that IV acetaminophen given in the pre-operative setting decreases post-operative nausea, vomiting, and/or pain and/or shortens recovery time, and improves patient satisfaction in regards to their pain management, it could also become a routine medication given to all patients in the pre-operative setting.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||82 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||A Double-blind Randomized, Placebo-controlled Study to Determine the Effectiveness of Pre-operative IV Acetaminophen Administration in Reducing Post-operative Pain, Nausea, and Vomiting in the Outpatient Setting|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||May 3, 2017|
|Actual Study Completion Date :||May 3, 2017|
Active Comparator: IV acetaminophen
Patients in the IV acetaminophen arm will receive a one gram dose of IV acetaminophen in the pre-operative area prior to their surgery.
Drug: IV acetaminophen
Single dose of one gram of IV acetaminophen given in pre-operative area
Placebo Comparator: Placebo
Patients in the placebo arm will receive normal saline in the pre-operative area.
placebo (IV normal saline)
- postoperative pain [ Time Frame: first postoperative day ]postoperative pain as measured by visual analog scale (VAS, range 0-10) measured in recovery room before discharge to outpatient setting
- postoperative nausea and vomiting (PONV) [ Time Frame: first postoperative day ]patient-rated postoperative nausea and vomiting (PONV) on visual analog scale
- time until readiness of discharge [ Time Frame: first postoperative day ]time until readiness of discharge: measured from arrival to the recover room to discharge-order-written time (DOW time)
- IV analgesic consumption in recovery room [ Time Frame: first postoperative day ]intravenous analgesic consumption in recovery room: converted to morphine-equivalents
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02102555
|United States, Iowa|
|Mercy Medical Center-Des Moines|
|Des Moines, Iowa, United States, 50314|
|Principal Investigator:||Lauren D Allan, DO||Mercy Medical Center-Des Moines General Surgery Residency|